LAUREN BALBAS: Open Payments
NPI 1417352345 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,775 in 70 payments from 18 companies in 2025. Trend: 2023 $880 · 2024 $1,322 · 2025 $2,775
Food & beverage: $2,753Travel & lodging: $23
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 6 | $441 |
| Novartis Pharmaceuticals Corporation | 8 | $342 |
| UCB, Inc. | 8 | $301 |
| Lilly USA, LLC | 5 | $301 |
| GENZYME CORPORATION | 5 | $260 |
| Incyte Corporation | 11 | $217 |
| Galderma Laboratories, L.P. | 4 | $206 |
| Biofrontera Inc. | 8 | $142 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $142 |
| LEO Pharma Inc. | 1 | $121 |
Products named: DUPIXENT, Bimzelx, Zoryve, EBGLYSS, COSENTYX, OPZELURA, NEMLUVIO, Rhapsido.
Industry payments across CA — which companies pay providers there.
